Business Standard

Reading the vital signs: Pharma sector, the market's trusted antidote

The pharma index was the only healthy pulse amid Friday's market declines

pharma medicine drugs
Premium

Among the top-listed pharma companies, average returns over the past few months have exceeded 20 per cent, except for Cipla.

Ram Prasad Sahu Mumbai
Amid valuation concerns, investors are playing it safe and turning to defensive sectors. The pharmaceutical (pharma) sector has benefited from this shift, attracting investors seeking steady cash flows. On Friday, while most sectoral indices closed in the negative, the pharma index was the only one to end with gains.

Over the past month, the National Stock Exchange Nifty Pharma, with a gain of 7 per cent, has outperformed other sectoral indices, while the Nifty 50’s returns were capped at 1.6 per cent.

Over the past three months, the pharma index was the second-highest gainer with a 14

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in